Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trial
Open Access
- 1 April 2011
- journal article
- research article
- Published by Taylor & Francis Ltd in Neuropsychiatric Disease and Treatment
- Vol. 7 (1), 209-215
- https://doi.org/10.2147/ndt.s18741
Abstract
Purpose: To examine the effects of Ginkgo biloba extract EGb 761® on neuropsychiatric symptoms of dementia. Patients and methods: Randomized, controlled, double-blind, multicenter clinical trial involving 410 outpatients with mild to moderate dementia (Alzheimer’s disease with or without cerebrovascular disease, vascular dementia), scoring at least 5 on the Neuropsychiatric Inventory (NPI), with at least one item score of 3 or more. Total scores on the SKT cognitive test battery (Erzigkeit’s short syndrome test) were between 9 and 23. After random allocation, the patients took 240 mg of EGb 761® or placebo once daily for a period of 24 weeks. Changes from baseline to week 24 in the NPI composite and in the SKT total score were the primary outcomes. The NPI distress score was chosen as a secondary outcome measure to evaluate caregivers’ distress. Results: The NPI composite score improved by -3.2 (95% confidence interval -4.0 to -2.3) in patients taking EGb 761® (n = 202), but did not change (-0.9; 0.9) in those receiving placebo (n = 202), which resulted in a statistically significant difference in favor of EGb 761® (P < 0.001). Treatment with EGb 761® was significantly superior to placebo for the symptoms apathy/indifference, sleep/night-time behavior, irritability/lability, depression/dysphoria, and aberrant motor behavior. Caregivers’ distress evaluation revealed similar baseline pattern and improvements. Conclusion: Treatment with EGb 761®, at a once-daily dose of 240 mg, was safe, effectively alleviated behavioral and neuropsychiatric symptoms in patients with mild to moderate dementia, and improved the wellbeing of their caregivers.Keywords
This publication has 45 references indexed in Scilit:
- Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational studyInternational Psychogeriatrics, 2010
- Effects of Ginkgo biloba in dementia: systematic review and meta-analysisBMC Geriatrics, 2010
- TheGinkgo bilobaextract EGb 761®and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortexBritish Journal of Pharmacology, 2010
- Behavioral and psychological symptoms associated with dementia subtype and severityInternational Psychogeriatrics, 2009
- Ginkgo-Spezialextrakt EGb 761® in der Behandlung der Demenz: Evidenz für Wirksamkeit und VerträglichkeitFortschritte der Neurologie · Psychiatrie, 2009
- Effects of Ginkgo biloba Extract EGb 761® on neuropsychiatric symptoms of dementia: findings from a randomised controlled trialWiener Medizinische Wochenschrift, 2007
- Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)Journal of Neural Transmission, 1999
- Dementia care in AsiaInternational Psychogeriatrics, 1999
- Demonstration of the “anti-stress” activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning taskGeneral Pharmacology: The Vascular System, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984